Schedule/Additional Infoexpand_more
Pathology Update: State-of-the-Art Diagnostic Approaches to Surgical Pathology – 2019
July 15-19, 2019
Add to Calendar Download
Hyatt Regency Toronto
370 King St. W Toronto ON  M5V 1J9 Canada


What’s New and Exciting in 2019!

  • Update on 8th Edition Staging
  • Brief review of basic principles of IHC including common pitfalls in daily practice
  • Introduction of new RNA in situ hybridization technics and their potential clinical application
  • Update on selected new IHC markers for diagnosis of neoplastic disease
  • Update on biomarker testing for immune checkpoint inhibitor therapy
  • Up to date information for predictive biomarkers in cancer - which tests, which genesCommonly-encountered grading and reporting issues in prostate cancer, along with pitfalls in prostate cancer diagnosis and how to avoid them
  • Benign mimics of urothelial carcinoma, under-recognized variants of urothelial carcinoma, and the importance of considering secondary malignancies of the bladder in the differential diagnosis
  • New markers for separating benign from malignant mesothelial proliferations




Pathology Update provides a state-of-the-art overview of surgical pathology. The value of the course comes directly from the expertise of the presenters and the real-world insights that they provide for your day-to-day practice. Pathology Update 2019 offers an exciting blend of returning and new experts who will discuss breast, gynecologic, head and neck, pulmonary, urologic, gastrointestinal, and dermatologic pathology, in addition to molecular and immunohistochemistry concepts and applications. Pathology Update will take you beyond the H&E to provide the latest knowledge about staging and tumor classification, prognostic factors, immunohistochemical profiles and molecular markers, important clinical trials, and novel therapeutic approaches.

Download PDF Order Form

Click here for course schedule


CREDITS:         33.75 CME Credits, 10.0 SAMs CME Credits


Following this course, you will be able to:

  • Apply the newly released 8th Edition staging to various type of tumors
  • Discuss the features that allow...
  • List Price: $1,494.00
  • Member Price: $1,149.00
Want to save more?
Log into see if you qualify for a lower rate.
Members save $345.00 or more Join